The value of CT-based radiomics nomogram in differential diagnosis of different histological types of gastric cancer

被引:0
作者
Hao Huang
Fangyi Xu
Qingqing Chen
Hongjie Hu
Fangyu Qi
Jiaojiao Zhao
机构
[1] Zhejiang University School of Medicine,Department of Radiology, Sir Run Run Shaw Hospital
[2] Nanxun District People’s Hospital,Department of Radiology
[3] Yuyao Traditional Chinese Medicine Hospital,Department of Radiology
来源
Physical and Engineering Sciences in Medicine | 2022年 / 45卷
关键词
Gastric cancer; Histological type; Radiomics; Computed tomography;
D O I
暂无
中图分类号
学科分类号
摘要
To establish and verify a nomogram based on computed tomography (CT) radiomics analysis to predict the histological types of gastric cancer preoperatively for patients with surgical indications. A sum of 171 patients with gastric cancer were included into this retrospective study. The least absolute shrinkage and selection operator (LASSO) was used for feature selection while the multivariate Logistic regression method was used for radiomics model and nomogram building. The area under curve (AUC) was used for performance evaluation in this study. The radiomics model got AUCs of 0.755 (95% CI 0.650–0.859), 0.71 (95% CI 0.543–0.875) and 0.712 (95% CI 0.500–0.923) for histological prediction in the training, the internal and external verification cohorts. The radiomics nomogram based on radiomics features and Carbohydrate antigen 125 (CA125) showed good discriminant performance in the training cohort (AUC: 0.777; 95% CI 0.679–0.875), the internal (AUC: 0.726; 95% CI 0.5591–0.8933) and external verification cohort (AUC: 0.720; 95% CI 0.5036–0.9358). The calibration curve of the radiomics nomogram also showed good results. The decision curve analysis (DCA) shows that the radiomics nomogram is clinically practical. The radiomics nomogram established and verified in this study showed good performance for the preoperative histological prediction of gastric cancer, which might contribute to the formulation of a better clinical treatment plan.
引用
收藏
页码:1063 / 1071
页数:8
相关论文
共 54 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Ferlay J(2019)The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of gastric cancer Cancer Commun 39 10-13704
[3]  
Soerjomataram I(2014)Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer BMC Cancer 14 773-20
[4]  
Wang FH(2014)Improving the outcomes in gastric cancer surgery World J Gastroenterol 20 13692-195
[5]  
Shen L(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-596
[6]  
Li J(2009)Preoperative treatment and surgery in gastric cancer: friends or foes? Lancet Oncol 10 191-1333
[7]  
Zhang ZY(2016)A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival Gastric Cancer 19 586-73
[8]  
Dai ZL(2016)A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer Br J Cancer 114 1326-v49
[9]  
Yin XW(2018)A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A) Gastric Cancer 21 68-37
[10]  
Tegels JJ(2016)Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v38-19